Delivery Order SPE2DE24D0013-SPE2D626F92C1
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a $8,640 delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28) on December 2, 2025, with an ultimate completion date of December 9, 2025. This firm fixed-price delivery order, designated XPRS4PLEX-10, contains no set-aside provisions and represents work to be performed at Cepheid's headquarters location in Sunnyvale, California. The contract involves the supply of diagnostic reagents and test kits for Cepheid's GeneXpert platform, which...
- The Defense Logistics Agency Medical Supply Chain has awarded a $2,024 delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28), a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems and reagents. This firm fixed-price delivery order, designated XPRSTREPA-10, was awarded on December 30, 2025, with an ultimate completion date of January 7, 2026, and carries no set-aside designation. The contract is for performance at Cepheid's Sunnyvale facility and represents a...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a $2,040 firm fixed-price delivery order (4570331464 | XPRS4PLEX-10) by the Defense Logistics Agency Medical Supply Chain on December 19, 2025, with an ultimate completion date of December 29, 2025. This delivery order, which carries no set-aside designation, is issued under Cepheid's larger Indefinite Delivery Contract with the Department of Veterans Affairs VISN 17, valued at $6.7...
- On January 8, 2026, the Defense Logistics Agency Medical Supply Chain awarded a $8,640 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28) for molecular diagnostic supplies and reagents. The delivery order, designated XPRS4PLEX-10, is scheduled for ultimate completion by January 15, 2026, and will be performed at Cepheid's headquarters in Sunnyvale, California. This award utilizes no set-aside designation and represents a child contract under Cepheid's existing Indefinite...
- The Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price delivery order valued at $1,750.00 to Cepheid Inc. (UEI: W6HQTMWB9Q28) on November 10, 2025, with an ultimate completion date of November 18, 2025. This delivery order, identified as GXMRSA-NXG-10, was issued without set-aside designation and is to be performed in Sunnyvale, California. Cepheid, a leading manufacturer of advanced molecular diagnostic systems headquartered in Sunnyvale, specializes in infectious...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $34,000 firm fixed-price delivery order (Contract 4570371726, XPRS4PLEX-10) by the Defense Logistics Agency Medical Supply Chain on December 29, 2025, with an ultimate completion date of January 6, 2026. This delivery order, which carries no set-aside designation, is issued under Cepheid's existing Indefinite Delivery Contract with the Department of Veterans Affairs Veterans Integrated Service Network (VISN) 17, valued at...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a $7,480 firm fixed-price delivery order by the Defense Logistics Agency Medical Supply Chain on January 7, 2026, with an ultimate completion date of January 14, 2026. This delivery order, valued at the ceiling amount, is issued under Cepheid's larger Indefinite Delivery Contract with the Department of Veterans Affairs Veterans Integrated Service Network 17, which is valued at $6.7...
- The U.S. Defense Health Agency, through the Medical Supply Chain, awarded a $40.8K firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28) on August 12, 2025, for molecular diagnostic solutions with an ultimate completion date of August 19, 2025. This delivery order, designated 4569068770 and titled XPCOV2/FLU/RSV-10, leverages Cepheid's expertise in infectious disease diagnostics and carries no set-aside designation. The work will be performed at Cepheid's facility in Sunnyvale,...
- The U.S. Defense Department's Medical Supply Chain awarded a $3,400 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28), a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This delivery order, issued on August 11, 2025, with an ultimate completion date of August 18, 2025, pertains to XPCOV2/FLU/RSV-10 testing capabilities and carries no set-aside designation. The contract represents work performed under Cepheid's larger indefinite delivery vehicles,...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $6,800 on January 7, 2026, by the Defense Logistics Agency Medical Supply Chain. This firm fixed-price delivery order, designated XPRS4PLEX-10, is scheduled for completion by January 14, 2026, and falls under Cepheid's existing Indefinite Delivery Contract with the Veterans Integrated Service Network 6 valued at $32.8M through September 30, 2030. No...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F92C1Delivery Order
The Defense Logistics Agency's Medical Supply Chain awarded a $3,400 delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28) on January 8, 2026, for molecular diagnostic supplies under contract XPRS4PLEX-10. This firm fixed-price delivery order, with an ultimate completion date of January 15, 2026, represents a child contract issued from Cepheid's broader Indefinite Delivery Vehicle with the Department of Veterans Affairs. The contract utilizes no set-aside designation and specifies performance at Cepheid's Sunnyvale, California headquarters. The delivery order likely involves XPRS4PLEX-10 diagnostic cartridges or related reagents for the GeneXpert diagnostic platform, consistent with Cepheid's core business of providing molecular diagnostic testing solutions for infectious diseases. Cepheid has established itself as a primary federal supplier of advanced molecular diagnostic systems, serving the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, Defense Logistics Agency, and the U.S. Coast Guard. The company's extensive federal contract portfolio includes two significant VA Indefinite Delivery Contracts—one with VISN 17 valued at approximately $6.7 million and another with VISN 6 valued at approximately $32.8 million—which serve as the contracting mechanisms for ongoing procurement of diagnostic reagents and testing solutions through 2029 and 2030, respectively. This modest delivery order exemplifies the routine, demand-driven procurement cycle supporting the federal government's diagnostic capabilities across distributed healthcare facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 1/7/26 |